8-K: Current report
Published on April 24, 2009
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of report (Date of earliest event reported): April 24, 2009
IDEXX
LABORATORIES, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
000-19271
|
01-0393723
|
|
(State
or other jurisdiction
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
of
incorporation)
|
|
One
IDEXX Drive, Westbrook, Maine
|
04092
|
|
(Address
of principal executive offices)
|
(ZIP
Code)
|
207.556.0300
(Registrant's
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. to Form 8-K):
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
|
Item
2.02
|
Results
of Operations and Financial
Condition.
|
On April 24, 2009, IDEXX Laboratories,
Inc. (the “Company”) announced its financial results for the quarter ended March
31, 2009. The full text of the press release issued in connection with the
announcement is furnished as Exhibit 99.1 to this Current Report on Form
8-K.
In accordance with general instructions
to Form 8-K, the information in this Form 8-K and the Exhibit 99.1 attached
hereto is being furnished under Item 2.02 and shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange
Act”) or otherwise subject to the liabilities of that section, nor shall it be
deemed incorporated by reference in any filing under the Securities Act of 1933
or the Exchange Act, except as expressly set forth by specific reference in such
a filing.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
|
(d)
|
Exhibits
|
The
following exhibit relating to Item 2.02 shall be deemed to be furnished, and not
filed.
|
99.1
|
Press
Release entitled “IDEXX Laboratories Announces First Quarter Results,”
issued by the company on April 24,
2009.
|
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
IDEXX
LABORATORIES, INC.
|
||
|
Date:
April 24, 2009
|
By:
|
/s/
Merilee Raines
|
|
Merilee
Raines
|
||
|
Corporate
Vice President and
Chief
Financial Officer
|
||
3
EXHIBIT
INDEX
|
Exhibit No.
|
Description of Exhibit
|
|
|
99.1
|
Press
Release entitled “IDEXX Laboratories Announces First Quarter Results,”
issued by the company on April 24,
2009.
|